An Ethical Analysis of Public Attitudes towards Controlled Human Infection Studies in Singapore: Acceptability and Payment
Barnaby Young, Alberto Giubilini, Xin Hui Sam, Tamra Lysaght, Paul Anantharajah Tambyah, G Owen Schaefer, Julian Savulescu

TL;DR
This study explores public attitudes in Singapore towards controlled human infection studies involving SARS-CoV-2 and examines ethical concerns, including participant payment.
Contribution
The study reveals Singaporeans' support for higher payment models in CHI studies and suggests that acceptability may not depend solely on institutional trust.
Findings
Most Singaporeans support CHI studies despite limited prior knowledge about them.
Participants favor higher payment rates, such as SGD$30 per hour.
Support for CHI studies in Singapore is comparable to the UK despite differing levels of public trust.
Abstract
Singapore is conducting its first controlled human infection (CHI) study, and is administering SARS-CoV-2 as the challenge agent. Ahead of this study, we conducted a survey to assess public perceptions in Singapore of CHI studies in general and with SARS-CoV-2, and the ethical issues they raise, including those around payments to research participants. Overall, there was large support for challenge studies in Singapore, suggesting they could obtain a social license. However, a minority strongly disagreed, and most respondents reported limited pre-survey knowledge about CHI studies. Importantly, Singaporeans support a higher incentive model of payment than is usually employed in challenge study research. They support either a Market Model or a Payment for Risk Model. There was most support for paying participants the highest rate offered—in our study, it was $SGD30 per hour. These…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsVaccine Coverage and Hesitancy · Ethics in Clinical Research · HIV, Drug Use, Sexual Risk
